SCHEMBL17876224

SCHEMBL17876224

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)CN(c1ccccc1)Cc1ccc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)cc1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.35
CHEK1 O14757 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABCB1 P08183 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
ALDH1A3 P47895 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
PTGER4 P35408 1/20 0.31
GABRA1 P14867 2/20 0.30
GABRG2 P18507 2/20 0.30
GABRB3 P28472 2/20 0.30
GABRA5 P31644 2/20 0.30
GABRA3 P34903 2/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17877910 0.97 MYC (0.35) MYCCHEK1KDM4EALDH1A1MAPT
SCHEMBL17877878 0.96 MYC (0.37) MYCCHEK1KDM4EALDH1A1MAPT
SCHEMBL17876223 0.90 KDM4E (0.39) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL17877876 0.89 PRKDC (0.32) KDM4EL3MBTL1CYP11B1CYP11B2
SCHEMBL17875822 0.88 MYC (0.38) MYCCHEK1KDM4EALDH1A1MAPT
SCHEMBL17875720 0.88 MYC (0.38) MYCCHEK1KDM4EALDH1A1MAPT
SCHEMBL17876225 0.88 CYP11B2 (0.40) MAPK1CYP1A2CYP3A4FLT3CYP11B1
SCHEMBL17877877 0.88 PRKDC (0.33) KDM4EL3MBTL1PTGER4CYP1A2CYP3A4
SCHEMBL17877905 0.87 KDM4E (0.35) KDM4EMAPTMAPK1TDP1L3MBTL1
SCHEMBL17877712 0.87 KDM4E (0.35) KDM4EMAPTMAPK1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MYC 2102/4885CHEK1 557/4885KDM4E 3120/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MYC 2102/4885CHEK1 557/4885KDM4E 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.